Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ashwani Verma is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $68.49 | 21.19% | $85 → $83 | Downgrade | Buy → Neutral | Get Alert |
| 06/03/2024 | RPRX | Buy Now | Royalty Pharma | $26.37 | 6.18% | → $28 | Downgrade | Buy → Neutral | Get Alert |
| 05/28/2024 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | 40.19% | $174 → $193 | Maintains | Buy | Get Alert |
| 04/23/2024 | BHVN | Buy Now | Biohaven | $34.71 | 72.86% | $59 → $60 | Maintains | Buy | Get Alert |
| 03/18/2024 | LEGN | Buy Now | Legend Biotech | $44.29 | 82.89% | $76 → $81 | Maintains | Buy | Get Alert |
| 03/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $106.73 | 22.74% | $135 → $131 | Maintains | Neutral | Get Alert |
| 02/20/2024 | ALKS | Buy Now | Alkermes | $24.10 | 3.73% | $25 → $25 | Downgrade | Neutral → Sell | Get Alert |
| 02/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $80.50 | 37.89% | → $111 | Initiates | → Buy | Get Alert |
| 02/06/2024 | BHVN | Buy Now | Biohaven | $34.71 | 69.98% | → $59 | Initiates | → Buy | Get Alert |
| 02/06/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $14.01 | 49.89% | → $21 | Initiates | → Buy | Get Alert |
| 01/24/2024 | CYTK | Buy Now | Cytokinetics | $54.18 | 69.8% | $61 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $68.49 | 19.73% | $74 → $82 | Maintains | Buy | Get Alert |
| 11/27/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $106.73 | 26.49% | $170 → $135 | Downgrade | Buy → Neutral | Get Alert |
| 11/27/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.23 | -19.9% | $11 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 10/17/2023 | ALKS | Buy Now | Alkermes | $24.10 | 28.63% | → $31 | Initiates | → Neutral | Get Alert |
| 10/17/2023 | ACLX | Buy Now | Arcellx | $55.19 | -5.78% | → $52 | Initiates | → Buy | Get Alert |
| 10/17/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 103.45% | → $33 | Initiates | → Buy | Get Alert |
| 09/20/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.23 | -32.22% | $8 → $11 | Maintains | Neutral | Get Alert |
| 08/07/2023 | COHR | Buy Now | Coherent | $72.46 | -90.34% | $11 → $7 | Maintains | Buy | Get Alert |
| 07/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -16.47% | $121 → $115 | Maintains | Buy | Get Alert |
| 07/06/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.23 | -50.71% | $7 → $8 | Upgrade | Sell → Neutral | Get Alert |
| 04/10/2023 | UTHR | Buy Now | United Therapeutics | $318.55 | -2.68% | $330 → $310 | Maintains | Buy | Get Alert |
| 04/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -9.2% | $137 → $125 | Maintains | Buy | Get Alert |
| 04/03/2023 | CYTK | Buy Now | Cytokinetics | $54.18 | 12.59% | $67 → $61 | Maintains | Buy | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $68.49 | -8.02% | $62 → $63 | Maintains | Buy | Get Alert |
| 03/28/2023 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 535.84% | → $11 | Upgrade | Neutral → Buy | Get Alert |
| 02/16/2023 | RPRX | Buy Now | Royalty Pharma | $26.37 | 82.03% | $51 → $48 | Maintains | Buy | Get Alert |
| 01/27/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $209 | Initiates | → Neutral | Get Alert |
| 12/15/2022 | CYTK | Buy Now | Cytokinetics | $54.18 | 21.82% | $80 → $66 | Maintains | Neutral | Get Alert |
| 12/06/2022 | LEGN | Buy Now | Legend Biotech | $44.29 | 49.02% | → $66 | Initiates | → Buy | Get Alert |
| 12/06/2022 | UTHR | Buy Now | United Therapeutics | $318.55 | 0.46% | → $320 | Initiates | → Buy | Get Alert |
| 11/10/2022 | VTRS | Buy Now | Viatris | $10.63 | 12.89% | $9 → $12 | Upgrade | Sell → Neutral | Get Alert |
| 10/11/2022 | RANI | Buy Now | Rani Therapeutics Hldgs | $4.00 | 275% | → $15 | Initiates | → Buy | Get Alert |
| 10/11/2022 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -1.21% | → $136 | Initiates | → Buy | Get Alert |
| 10/11/2022 | CYTK | Buy Now | Cytokinetics | $54.18 | 47.66% | → $80 | Initiates | → Buy | Get Alert |
| 08/04/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $106.73 | 78.96% | $194 → $191 | Maintains | Buy | Get Alert |
| 08/04/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $137 → $71 | Downgrade | Buy → Neutral | Get Alert |
| 07/05/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $139 → $137 | Maintains | Buy | Get Alert |
| 06/14/2022 | VTRS | Buy Now | Viatris | $10.63 | -15.33% | → $9 | Initiates | → Sell | Get Alert |
| 06/14/2022 | RPRX | Buy Now | Royalty Pharma | $26.37 | 78.23% | → $47 | Initiates | → Buy | Get Alert |
| 06/14/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.23 | -38.39% | → $10 | Initiates | → Neutral | Get Alert |
| 06/14/2022 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 304.62% | → $7 | Initiates | → Neutral | Get Alert |
| 06/14/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $68.49 | 9.51% | → $75 | Initiates | → Buy | Get Alert |
| 06/14/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $106.73 | 81.77% | → $194 | Initiates | → Buy | Get Alert |
| 06/14/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | → $139 | Initiates | → Buy | Get Alert |
| 06/14/2022 | DHT.UN | Buy Now | DRI Healthcare Trust | — | — | → $10 | Initiates | → Buy | Get Alert |
